ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Medical Equipment, Supplies & Distribution

Delayed Hong Kong S.E. Other stock markets 04:09:09 2024-04-25 am EDT			5-day change	1st Jan Change
10.24 ^HKD	-2.48%		+8.02%	-17.68%

Mar. 22	Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	MT
Mar. 21	Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Wire Sciences Medical Technology Co., Ltd announced that it expects to receive funding from Zylox-Tonbridge Medical Technology Co., Ltd.

January 16, 2022

Wire Sciences Medical Technology (Suzhou) Co., Ltd announced that it has entered into a capital increase agreement for private placement of common shares on January 17, 2022. The transaction will include participation from new investor Zylox-Tonbridge Medical Technology Co., Ltd.

Latest news about Zylox-Tonbridge Medical Technology Co., Ltd.

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	Mar. 22	MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	Mar. 07	MT
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	Mar. 07	MT
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	Mar. 06	CI
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd.	Mar. 03	CI
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	Feb. 21	CI
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%	Jan. 22	MT
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	Jan. 21	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	Dec. 28	CI
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device	Dec. 29	MT
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU	Dec. 21	MT
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	Dec. 20	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	Dec. 11	CI
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter	Dec. 11	MT
China Gives Marketing Approval for Zylox-Tonbridge's Blood Vessel Distal Support Catheter	Dec. 06	MT
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Address of Registered Office	Nov. 07	CI
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	Nov. 07	CI
Zylox-Tonbridge Trustee Buys About 1.1 Million Shares Under Share Award, Trust Scheme; Shares Jump 5%	Nov. 05	MT
Zylox-Tonbridge Medical Buys Back 1.1 Million Shares	23-10-13	MT
Zylox-Tonbridge Medical Technology Shareholders Approve Buyback Mandate	23-09-27	MT
Zylox Tonbridge Unaware of Reasons Behind Stock Movement	23-09-22	MT
Zylox-Tonbridge Medical Technology Co., Ltd.'S ZENFlow Tiger? LD PTA Dilatation Catheter Receives ANVISA Marketing Approval	23-08-30	CI
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Zylox-Tonbridge Medical Signs Collaboration Deal for Sale of Surgical Guidewire Products in China	23-04-21	MT

Chart Zylox-Tonbridge Medical Technology Co., Ltd.

Duration

Period

Chart Zylox-Tonbridge Medical Technology Co., Ltd.

More charts

Company Profile

Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Zylox-Tonbridge Medical Technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.477 CNY

Average target price

14.11 CNY

Spread / Average Target

+48.86%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.	-17.68%	439M
STRYKER CORPORATION	+12.59%	128B
SMITH & NEPHEW PLC	-10.58%	10.66B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.39%	8.55B
INSPIRE MEDICAL SYSTEMS, INC.	+13.56%	7.1B
GLAUKOS CORPORATION	+25.94%	5.06B
AXONICS, INC.	+6.93%	3.4B
ENOVIS CORPORATION	-1.64%	3.08B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.96%	2.11B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-7.25%	2.03B

Medical Devices & Implants